ProfileGDS4718 / 200928_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 51% 59% 60% 56% 70% 46% 39% 56% 59% 64% 74% 63% 56% 46% 56% 57% 67% 51% 49% 35% 50% 66% 64% 64% 58% 50% 69% 50% 64% 38% 64% 40% 57% 68% 38% 51% 44% 53% 58% 59% 65% 42% 45% 33% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.5553351
GSM549102patient 115, normal, homogenized [OPG study]6.0592559
GSM549104patient 119, normal, homogenized [OPG study]6.1693960
GSM549108patient 138, normal, homogenized [OPG study]5.9121156
GSM549119patient 077, normal, homogenized [OPG study]6.8779170
GSM549133patient 032, cancer, homogenized [OPG study]5.2244946
GSM549139patient 042, cancer, homogenized [OPG study]4.9080739
GSM549099patient 107, normal, homogenized [OPG study]5.8470756
GSM549109patient 139, normal, homogenized [OPG study]6.0789159
GSM549110patient 046, normal, homogenized [OPG study]6.3669964
GSM549114patient 063, normal, homogenized [OPG study]7.2101174
GSM549122patient 082, normal, homogenized [OPG study]6.3204863
GSM549134patient 033, cancer, homogenized [OPG study]5.8670156
GSM549136patient 036, cancer, homogenized [OPG study]5.2464946
GSM549140patient 044, cancer, homogenized [OPG study]5.809156
GSM549111patient 047, normal, homogenized [OPG study]5.9196557
GSM549113patient 057, normal, homogenized [OPG study]6.6296967
GSM549132patient 031, cancer, homogenized [OPG study]5.5511551
GSM549137patient 038, cancer, homogenized [OPG study]5.440249
GSM549142patient 047, cancer, homogenized [OPG study]4.8622135
GSM549100patient 110, normal, homogenized [OPG study]5.515750
GSM549107patient 135, normal, homogenized [OPG study]6.5284166
GSM549115patient 068, normal, homogenized [OPG study]6.4116864
GSM549116patient 072, normal, homogenized [OPG study]6.3891364
GSM549120patient 078, normal, homogenized [OPG study]5.9633658
GSM549131patient 030, cancer, homogenized [OPG study]5.4645250
GSM549118patient 074, normal, homogenized [OPG study]6.7701669
GSM549129patient 027, cancer, homogenized [OPG study]5.5535450
GSM549123patient 088, normal, homogenized [OPG study]6.4198464
GSM549124patient 006, cancer, homogenized [OPG study]4.9239738
GSM549126patient 015, cancer, homogenized [OPG study]6.3839764
GSM549128patient 025, cancer, homogenized [OPG study]4.9900640
GSM549103patient 117, normal, homogenized [OPG study]5.9484557
GSM549117patient 073, normal, homogenized [OPG study]6.6612968
GSM549138patient 041, cancer, homogenized [OPG study]4.8695238
GSM549141patient 045, cancer, homogenized [OPG study]5.5326351
GSM549130patient 028, cancer, homogenized [OPG study]5.2136544
GSM549101patient 111, normal, homogenized [OPG study]5.7383753
GSM549105patient 128, normal, homogenized [OPG study]5.9770558
GSM549106patient 134, normal, homogenized [OPG study]6.0605559
GSM549112patient 048, normal, homogenized [OPG study]6.4900565
GSM549125patient 011, cancer, homogenized [OPG study]5.1154542
GSM549127patient 024, cancer, homogenized [OPG study]5.2447645
GSM549135patient 035, cancer, homogenized [OPG study]4.6164833